Anti-toll like receptor 4 (TLR4) therapy diminishes cardiac remodeling regardless of changes in blood pressure in spontaneously hypertensive rats (SHR)

Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSPECHEM, CinthyaBOMFIM, Gisele FacholiCERAVOLO, Graziela ScaliantiOLIVEIRA, Maria AparecidaSANTOS-EICHLER, Rossngela AparecidaBECHARA, Luiz RobertoVERAS, Mariana MateraSALDIVA, Paulo Hilario NascimentoFERREIRA, Julio CesarAKAMINE, Eliana HiromiFORTES, Zuleica BrunoDANTAS, Ana PaulaCARVALHO, Maria Helena Catelli de2015-10-262015-10-262015INTERNATIONAL JOURNAL OF CARDIOLOGY, v.187, p.243-245, 20150167-5273https://observatorio.fm.usp.br/handle/OPI/11821engrestrictedAccessArterial hypertensionToll-like receptor 4 (TLR4)Cardiac hypertrophyCardiac fibrosisCardiac inflammationSpontaneously hypertensive rats (SHR)hypertrophydiseaseheartAnti-toll like receptor 4 (TLR4) therapy diminishes cardiac remodeling regardless of changes in blood pressure in spontaneously hypertensive rats (SHR)articleCopyright ELSEVIER IRELAND LTD10.1016/j.ijcard.2015.03.190Cardiac & Cardiovascular Systems1874-1754